TBD
Past New Requirement Updated
- Agency
-
Indian Health Service
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $7,000,000 to $13,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Points of contact
-
- Sean Long sean.long@ihs.gov (918) 342-6509
- Timothy Cardenaz timothy.cardenaz@ihs.gov (405) 951-6000
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Indian Health Service (IHS) is forecasting a federal contract opportunity for flu-related biological product manufacturing, with an estimated award date of July 1, 2026. The contract falls under the Biological Product Manufacturing NAICS code 325414 and does not have a specific set-aside designation. The current incumbent contractors include Seqirus, Sanofi, and GSK, suggesting this is a potential re-competition or expanded procurement for flu-related medical products.
While specific award value details are not provided, the contract involves biological product manufacturing in the healthcare sector, specifically focused on flu-related products. The point of contact for this opportunity is Sean Long, Contracting Officer, who can be reached at sean.long@ihs.gov or +1 (405) 951-3932, with additional coordination from Aaron Cardenaz, Program Manager, contactable at timothy.cardenaz@ihs.gov or +1 (405) 951-6000. The procurement is being managed directly by the Indian Health Service, indicating the potential performance location will likely involve IHS healthcare facilities or designated manufacturing sites.
Forecast text
Flu
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast